Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | F7 | P08709 | 3/20 | 0.51 |
| ▸ | F3 | P13726 | 3/20 | 0.51 |
| ▸ | PPARG | P37231 | 2/20 | 0.51 |
| ▸ | PPARD | Q03181 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | FABP3 | P05413 | 2/20 | 0.51 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.51 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.51 |
| ▸ | FABP4 | P15090 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4602226 | 0.94 | MEN1 (0.53) | KDM4ESOAT1TRPV1ALDH1A1FFAR1 | |
| SCHEMBL22472222 | 0.94 | MEN1 (0.53) | KDM4ESOAT1TRPV1ALDH1A1FFAR1 | |
| SCHEMBL21122072 | 0.85 | KDM4E (0.55) | KDM4ESOAT1TRPV1CNR1ALDH1A1 | |
| SCHEMBL21122063 | 0.85 | KDM4E (0.55) | KDM4ESOAT1TRPV1CNR1ALDH1A1 | |
| SCHEMBL21199791 | 0.85 | KDM4E (0.55) | KDM4ESOAT1TRPV1CNR1ALDH1A1 | |
| SCHEMBL21122071 | 0.85 | KDM4E (0.55) | KDM4ESOAT1TRPV1CNR1ALDH1A1 | |
| SCHEMBL21248646 | 0.85 | KDM4E (0.55) | KDM4ESOAT1TRPV1CNR1ALDH1A1 | |
| SCHEMBL21248537 | 0.85 | KDM4E (0.55) | KDM4ESOAT1TRPV1CNR1ALDH1A1 | |
| SCHEMBL21253120 | 0.85 | KDM4E (0.55) | KDM4ESOAT1TRPV1CNR1ALDH1A1 | |
| SCHEMBL21122062 | 0.85 | KDM4E (0.55) | KDM4ESOAT1TRPV1CNR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116835903-B | Shrinkage-reducing alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-118284419-A | Methods of treating post-traumatic stress disorder | 杰资制药爱尔兰有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-117957234-A | Thienopyrrole compounds | 吉利德科学公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117120450-A | Thienopyrrole compounds | 吉利德科学公司 | 2023-11-24 | — | — | CN | claimed |
| CN-117069411-A | Multi-ring structure shrinkage reducing agent, alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116835903-A | Shrinkage-reducing alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116783202-A | Thienopyrrole compounds | 吉利德科学公司 | 2023-09-19 | — | — | CN | claimed |
| CN-116835903-B | Shrinkage-reducing alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | UNIV JOHNS HOPKINS (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4577247-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | The Johns Hopkins University (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4003384-B1 | AN EXTRACT FROM CANNABIS AND PEGANUM | T C ERCIYES UNIV (TR) | 2025-06-25 | — | — | EP | disclosed |
| WO-2025108106-A1 | COMPOUND CONTAINING QUINOLINONE SKELETON AND USE THEREOF | 中国药科大学 | 2025-05-30 | — | — | WO | disclosed |
| CN-119881144-A | Method for extracting and detecting lipid in liquid milk raw milk | 上海市质量监督检验技术研究院 | 2025-04-25 | — | — | CN | disclosed |
| WO-2007030697-A2 | MODULATION OF NEUROGENESIS BY HDAC INHIBITION | BRAINCELLS, INC. (US) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007025177-A2 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS, INC. (US) | 2007-03-01 | — | — | WO | disclosed |
| US-20070049576-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS, INC. (US) | 2007-03-01 | — | — | US | disclosed |
| WO-2006133926-A1 | PYRAZOLE DERIVATES AS CANNABINOID RECEPTOR MODULATORS | CAREX SA (FR) | 2006-12-21 | — | — | WO | disclosed |
| WO-2005113600-A2 | METHODS FOR THE CONTROL, TREATMENT AND MANAGEMENT OF OBESITY | HAPTOGEN LTD (GB) | 2005-12-01 | — | — | WO | disclosed |
| US-20040132819-A1 | Appetite control method | ABBOTT LABORATORIES | 2004-07-08 | — | — | US | disclosed |
| WO-2004012727-A1 | COMPOSITIONS COMPRISING POLYSATURATED FATTY ACID (PUFAS) FOR THE CONTROL OF APPETITE AND BODY WEIGHT MANAGEMENT | ABBOTT LABORATORIES (US) | 2004-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | CNR1, CNR2, GPR18 | KDM4E 1372/4885SOAT1 2211/4885TRPV1 34/4885 |
| US-20070049576-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | CHRNB2, CHAT, CHRNB4 | KDM4E 2095/4885SOAT1 2682/4885TRPV1 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.